C-Pulse® System: A Heart Assist Device Clinical Study



Status:Completed
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:12/27/2018
Start Date:September 12, 2012
End Date:October 26, 2018

Use our guide to learn which trials are right for you!

C-Pulse Heart Assist Device pivOtal stUdy treatiNg paTients With modERate to Severe Heart Failure C-Pulse® System: A Heart Assist Device Pivotal IDE Study

Sunshine Heart is sponsoring a prospective, multi-center, randomized trial to assess the
safety and efficacy of the C-Pulse® System ("C-Pulse").

The purpose of the study is to determine whether the use of the C-Pulse as a treatment for
patients in moderate to severe heart failure (HF) has demonstrated safety and efficacy, such
that the C-Pulse System merits Food and Drug Administration (FDA) approval to market the
device in the United States.

The C-Pulse® System is indicated for use in patients with moderate to severe heart failure
while on optimal heart failure drug and on device therapies. The C-Pulse® System is intended
to relieve the symptoms of heart failure, improve quality of life and cardiac function, and
reduce the need for heart failure hospitalization. It is intended for use in hospital and at
home. It is not intended as a replacement for heart function; it is not life sustaining or
life-supporting therapy. It does not preclude the use of other heart failure therapies, such
as valve surgery, heart transplantation or LVAD.

The Sunshine Heart C-Pulse System is an implantable, non-blood contacting, non-obligatory,
heart assist device. The system provides cardiac assistance through an extra-aortic balloon
Cuff and ECG sense lead connected by means of a Percutaneous Interface Lead (PIL) to an
external pneumatic Driver. The PIL is held secure externally, at the exit site, with a simple
adhesive clip (C-Patch or similar) for immobilization of the external part of the PIL. The
Driver is adjusted using a dedicated notebook computer (Programmer) with specialized
software.

The non-blood contacting feature of the C-Pulse® System also allows the device to be
intermittently turned off as tolerated. This allows the patient freedom for personal hygiene.

Inclusion Criteria:

1. Left ventricular ejection fraction (LVEF) ≤ 35% (by transthoracic ECHO within 90 days
prior to randomization)

2. ACC/AHA Stage C and NYHA III to ambulatory Class IV

3. Age ≥ 18 years

4. Must have cardiac resynchronization therapy (CRT) when clinically indicated, implanted
≥90 days prior to randomization.

5. Must have an implanted cardio-defibrillator (ICD) when clinically indicated, implanted
at least 30 days prior to randomization.

Note: If a subject is clinically indicated for an ICD but refuses the ICD, he/she may
be enrolled. Please document the refusal of the ICD in the medical record and the
eCRFs.

6. Patient must be on stable, up-titrated medical therapy as recommended according to
current guidelines (Circulation. 2009; 119 (12): 1977-2016) which minimally includes:

- ACE-inhibitor (ACE-I) at stable doses for 1 month prior to enrollment, if
tolerated, AND

- a beta blocker (carvedilol, sustained release metoprolol succinate, or
bisoprolol) for 3 months prior to enrollment, if tolerated, with a stable
up-titrated dose for 1 month prior to enrollment.

- This also includes an Angiotensin II Receptor Blocker (ARB) at stable doses for 1
month prior to enrollment, if tolerated, when ACE-I is not tolerated.

- Stable is defined as no more than a 100% increase or a 50% decrease in dose. If
the patient is intolerant to ACE-I, ARB, or beta blockers, documented evidence
must be available.

- In those intolerant to both ACE-I and ARB, combination therapy with hydralazine
and oral nitrate should be considered. Therapeutic equivalence for ACE-I
substitutions is allowed within the enrollment stability timelines.

- Aldosterone inhibitor therapy should be added. Eplerenone requires dosage
stability for 1 month prior to enrollment.

- Diuretics may be used as necessary to keep the patient euvolemic.

7. Functional limitation due to heart failure as defined by a 6 Minute Walk test of ≥ 175
≤ 375 meters, measured within 30 days prior to randomization

8. At least one hospitalization for decompensated heart failure as defined below, while
on heart failure medications, within 12 months prior to randomization or BNP level >
300 or NTproBNP > 1500

Heart failure related hospitalization is defined by the following:

- signs and symptoms of worsening heart failure; and

- treatment with intravenous heart failure therapy (including but not limited to
diuretic or inotropic therapy) and

- a minimum of one date change in the hospital

9. Patient understands the nature of the procedure and on-going device therapy, is
willing to comply with associated follow-up evaluations, and provide written informed
consent prior to the procedure.

Exclusion Criteria:

1. Any evidence, as assessed within 90 days prior to enrollment, of either:

1. Ascending aortic calcification on posterior-anterior or lateral chest x-ray

2. Calcific ascending aortic disease as detected by non-contrast CT scan

3. Ascending aorto-coronary artery bypass grafts, history of aortic dissection,
Marfans disease or other connective tissue disorder or repaired aortic
coarctation OR

4. Has had an ascending aortic composite graft or root replacement

2. Aorta not conforming to specified dimensional constraints defined by CT scan, most
specifically mid ascending aortic outside diameter less than 28 mm or greater than 42
mm

3. Inotrope dependence - inability to wean from inotropic therapy

4. ACC/AHA Stage D heart failure or non-ambulatory NYHA Class IV subject

5. Hypertrophic obstructive cardiomyopathy, restrictive cardiomyopathy, pericardial
disease, amyloidosis, active myocarditis, diastolic heart failure or technically
challenging congenital heart disease

6. Reversible cause of heart failure that may be remedied by conventional surgery or
other intervention

7. Moderate to severe aortic insufficiency (≥ 2+)

8. ST elevation myocardial infarction (STEMI) within 30 days prior to randomization

9. Cardiac surgery within 90 days prior to randomization

10. Prior cardiac transplantation, left ventricular reduction surgery, passive restraint
device or surgically implanted left ventricular assist device

11. Anticipated concomitant cardiac surgical procedure

12. Serum creatinine ≥ 2.5mg/dL or any form of dialysis within 30 days prior to
randomization

13. Evidence of intrinsic hepatic disease as defined as biopsy proven liver cirrhosis; or
liver enzyme values (AST, ALT or total bilirubin) that are > 3 times the upper limit
of normal within 30 days prior to randomization

14. Patient has severe intrinsic pulmonary disease in judgment of the investigator

15. Body Mass Index (BMI) < 18 or > 45 kg/m2

16. Suspected or active systemic infection

1. Within 14 days prior to randomization and

2. Evidenced by positive culture, antibiotics for empiric treatment or elevated WBC
> 12K and temperature >38o C

17. Stroke or transient ischemic attack (TIA) within the 90 days prior to randomization;
or > 80% carotid stenosis as determined by carotid Doppler ultrasound within 90 days
prior to randomization

18. Positive serum pregnancy test, for women of childbearing potential

19. Patient has a condition, other than heart failure, which would limit survival to less
than 2 years

20. Patient is currently enrolled or has participated in the last 30 days in another
therapeutic or interventional clinical study

21. Patient demonstrates compliance issues that in the opinion of the investigator could
interfere with the ability to manage the therapy (i.e. uncontrolled diabetes, mental
health issues, etc.)
We found this trial at
28
sites
Clearwater, Florida 33756
?
mi
from
Clearwater, FL
Click here to add this to my saved trials
2500 N State St
Jackson, Mississippi 39216
(601) 984-1000
University of Mississippi Medical Center The University of Mississippi Medical Center, located in Jackson, is...
?
mi
from
Jackson, MS
Click here to add this to my saved trials
777 Hemlock Street
Macon, Georgia 31201
(478) 633-1000
Medical Center of Central Georgia Navicent Health is a designated Level I Trauma Center and...
?
mi
from
Macon, GA
Click here to add this to my saved trials
Miami, Florida 33136
?
mi
from
Miami, FL
Click here to add this to my saved trials
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
?
mi
from
Nashville, TN
Click here to add this to my saved trials
3400 Spruce St
Philadelphia, Pennsylvania 19104
 (215) 662-4000
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
?
mi
from
Columbus, OH
Click here to add this to my saved trials
4500 S. Lancaster Rd.
Dallas, Texas 75216
800-849-3597
Dallas VA Medical Center VA North Texas Health Care System (VANTHCS) is a progressive health...
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Hershey, Pennsylvania 17033
?
mi
from
Hershey, PA
Click here to add this to my saved trials
Hollywood, Florida
?
mi
from
Hollywood, FL
Click here to add this to my saved trials
Houma, Louisiana 70360
?
mi
from
Houma, LA
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
Lincoln, Nebraska 68526
?
mi
from
Lincoln, NE
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Louisville, Kentucky 40202
?
mi
from
Louisville, KY
Click here to add this to my saved trials
1514 Jefferson Hwy.
New Orleans, Louisiana 70121
504-842-3000
Ochsner Medical Center Ochsner Medical Center is located near uptown New Orleans and includes acute...
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
201 Lyons Ave
Newark, New Jersey 07112
(973) 926-7000
Newark Beth Israel Medical Center Newark Beth Israel Medical Center, a regional care, teaching hospital...
?
mi
from
Newark, NJ
Click here to add this to my saved trials
1801 N Broad St
Philadelphia, Pennsylvania 19122
(215) 204-7000
Temple University Temple University is many things to many people. A place to pursue life's...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Richmond, Virginia 23298
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Saint Louis, Missouri 63136
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
San Francisco, California 94143
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Spokane, Washington 99204
?
mi
from
Spokane, WA
Click here to add this to my saved trials
Valhalla, New York 10595
?
mi
from
Valhalla, NY
Click here to add this to my saved trials